{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:12:27Z","timestamp":1790161947495,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014181","name":"Junta de Extremadura","doi-asserted-by":"publisher","award":["GR21026"],"award-info":[{"award-number":["GR21026"]}],"id":[{"id":"10.13039\/501100014181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00745"],"award-info":[{"award-number":["PI18\/00745"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00181"],"award-info":[{"award-number":["PI22\/00181"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0031"],"award-info":[{"award-number":["RD21\/0005\/0031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Serum creatinine and albuminuria are the core of most CKD prediction and progression risk models. Several biomarkers have been introduced to improve these results such as beta\u20102\u2010microglobulin (B2M) and cystatin C (CysC). Nevertheless, few clinical comparisons of these biomarkers are available. We have compared serum B2M levels with albuminuria, CysC levels, and the CKD\u2010EPI GFR equations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Designs and Methods<\/jats:title><jats:p>A sample of 434 patients were studied: 234 males and 200 females, the mean age was 58.3\u2009\u00b1\u200915.0\u2009years, and 33.4% have diabetes mellitus. In all patients, plasma B2M, CysC, creatinine, and urinary albumin excretion were analyzed. EGFR was calculated using CKD\u2010EPI equations for creatinine, CysC, and creatinine\u2010CysC. The risk of death and CKD progression was evaluated using ROC curves and Cox proportional hazards survivorship models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For mortality, the highest area under the curve (AUC) was for CysC (0.775, 0.676\u20130.875). The lowest sensitivity was shown by eGFR (creatinine) (0.298, 0.195\u20130.401, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), eGFR (CysC) (0.216, 0.118\u20130.314, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and eGFR (creatinine + CysS) (0.218, 0.124\u20130.312, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). For progression to advanced CKD, the highest AUC was for CysC (0.908, 0.862\u20130.954). The lowest sensitivity was shown by eGFR (creatinine) (0.184, 0.106\u20130.261, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), eGFR (CysC) (0.095, 0.048\u20130.14, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and eGFR (creatinine+ CysC) (0.087, 0.040\u20130.134, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). CysC, after age, was the second\u2010best marker of life risk. Contrariwise, for CKD progression, CysC, and albuminuria were the best markers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The best biomarker of mortality and risk of progression to CKD was CysC. Albuminuria and B2M were the next best options to be used. The lowest sensitivity was shown by estimated eGFR.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcla.25139","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:09:44Z","timestamp":1734955784000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta\u20102\u2010Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0856-5845","authenticated-orcid":false,"given":"Isis","family":"Cerezo","sequence":"first","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-4040","authenticated-orcid":false,"given":"Barbara","family":"Cancho","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alberto","family":"Rodriguez Sabillon","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-770X","authenticated-orcid":false,"given":"Alberto","family":"Jorge","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-9469","authenticated-orcid":false,"given":"Alvaro","family":"Alvarez Lopez","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-9767","authenticated-orcid":false,"given":"Julian","family":"Valladares","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-4231","authenticated-orcid":false,"given":"Juan","family":"Lopez Gomez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6366-2197","authenticated-orcid":false,"given":"Jorge","family":"Romero","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Interna Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-6691","authenticated-orcid":false,"given":"Nicolas Roberto","family":"Robles","sequence":"additional","affiliation":[{"name":"Servicio de Nefrologia Hospital Universitario de Badajoz, Universidad de Extremadura  Badajoz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989"},{"issue":"3","key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","journal-title":"Kidney International"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.451"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CP0070058"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1543"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.10.014"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133312.96477.48"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00040-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08870812"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011070663"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200111000-00009"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.119669"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.12.015"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0003202022"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0003202022"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270289"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155735"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129269"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2018.10.005"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-023-02392-4"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.23.127"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.01.016"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.11.042"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.01.015"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005020132"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005091012"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"issue":"1","key":"e_1_2_7_32_1","first-page":"47","article-title":"Prognostic Value of the Short\u2010Term Antiproteinuric Response to ACE Inhibition for Prediction of GFR Decline in Patients With Nondiabetic Renal Disease","volume":"4","author":"Wapstra F. H.","year":"1996","journal-title":"Experimental Nephrology"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2011.10.002"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu261"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs263"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6634"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009050546"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.09.016"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.20.2212"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00470111"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00003"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.25139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:27:12Z","timestamp":1738168032000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.25139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1002\/jcla.25139"],"URL":"https:\/\/doi.org\/10.1002\/jcla.25139","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25139"}}